Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03579654
Recruitment Status : Not yet recruiting
First Posted : July 6, 2018
Last Update Posted : March 6, 2019
Sponsor:
Information provided by (Responsible Party):
OncBioMune Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : February 28, 2021
Estimated Study Completion Date : June 30, 2022